Pacemaker, Model 252, C-MOS
by Intermedics, Inc. 510(k)
Active
510(k) K780437
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK780437 | Date5 Apr 1978 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Recalls
No FDA recalls on record, checked 22 Oct 2026.
Specification
- 510(k) Number
- FDA Product Code
- DXY
- Device Class
- Class III
- Regulation
- 21 CFR Part 870.3610
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The Pacemaker, Model 252, C-MOS is an Implantable Pacemaker Pulse-Generator, a Class III medical device designed to regulate heart rhythm by delivering electrical impulses to the heart when necessary. It is intended for patients with bradycardia or other conduction disorders requiring artificial pacing to maintain proper cardiac function.
This device is supplied sterile and intended for single-use implantation, adhering to 21 CFR 870.3610 under product code DXY. Authorized by FDA 510(k) clearance (K780437), it was reviewed by the Cardiovascular Advisory Committee in 1978 and classified as substantially equivalent to predicate devices. Storage and handling must comply with sterile implantable device protocols.
Other devices from Intermedics, Inc.
Questions
AI-generated answers, 18 Sep 2026
What is the primary purpose of the Pacemaker, Model 252, C-MOS, and who is it designed for?
The Pacemaker, Model 252, C-MOS is designed to regulate heart rhythm by delivering electrical impulses to the heart when needed. It is intended for patients with bradycardia or other conduction disorders that require artificial pacing to maintain proper cardiac function.
Is this device intended for single-use or reusable implantation, and how should it be handled?
This device is supplied sterile and intended for single-use implantation only. Since it is classified as an implantable device, storage and handling must strictly follow sterile implantable device protocols to ensure patient safety.
What regulatory pathway was followed for FDA clearance of this device, and what does that mean for its use?
The Pacemaker, Model 252, C-MOS received FDA 510(k) clearance (K780437) through a traditional review process, determined to be substantially equivalent to predicate devices. This means it was evaluated by the FDA’s Cardiovascular Advisory Committee in 1978 and deemed compliant with existing safety and performance standards for implantable pacemakers.
How is this device classified, and what does that classification imply for its use in clinical settings?
This device is classified as a Class III medical device under the FDA’s regulatory framework, which applies to high-risk devices requiring strict pre-market approval or clearance. As an implantable pacemaker, it falls under 21 CFR 870.3610 and is intended for critical cardiac rhythm management, requiring careful clinical assessment before implantation.